What is the basis for therapy selection in relapsed acute lymphoblastic leukemia (ALL)?

Updated: Oct 26, 2020
  • Author: Karen Seiter, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

The choice of therapy a patient will receive depends on the following:

  • The front-line regimen they received
  • The duration of prior remission
  • Whether the patient relapsed after transplantation
  • The comorbidities that the patient has

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!